The Economic Costs of Undiagnosed Diabetes
Although the high prevalence of UDM makes it an important health issue to be studied, data limitations have contributed to a dearth of information on the health care use patterns and economic costs of UDM. By omitting UDM, estimates of the total national cost of diabetes are underestimated (Population Health Management)
Postprandial hyperglycemia as an etiological factor in vascular failure
Postprandial hyperglycemia is therefore one of the very important pathophysiological states contributing to vascular failure. Accordingly, controlling postprandial hyperglycemia should be the focus of future clinical investigation as a potential target for preventing vascular failure (Cardiovascular Diabetology)
Insulet wins EU OK to sell insulin pump
The European Union has awarded Bedford-based insulin pump products maker Insulet Corp. the right to market its goods in Europe (MHT)
A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes
The goal of this study was to compare daily insulin use, glycemic control, and health care costs in insulin-naive patients with type 2 diabetes who initiated treatment with either insulin detemir or insulin glargine (Clinical Therapeutics – via PubMed)
Vascular Programme briefing packs
The pack covers coronary heart disease, stroke, diabetes and renal disease (NHS Diabetes)
Glycosmedia is also available as an App: